351 related articles for article (PubMed ID: 4028596)
1. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
Huckell VF; Lyster DM; Morrison RT; Cooper JA
Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
3. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction.
Wheelan K; Wolfe C; Corbett J; Rude RE; Winniford M; Parkey RW; Buja LM; Willerson JT
Am J Cardiol; 1985 Aug; 56(4):252-6. PubMed ID: 4025161
[TBL] [Abstract][Full Text] [Related]
4. [Bayesian analysis of myocardial scintigraphy using 99mTc-Sn(II)-methylenediphosphonate and using 99mTc-Sn(II)-pyrophosphate].
Cuarón A; Acero A; Cárdenas M
Arch Inst Cardiol Mex; 1982; 52(5):365-72. PubMed ID: 7149857
[TBL] [Abstract][Full Text] [Related]
5. Value and limitations of technetium-99m stannous pyrophosphate in the detection of acute myocardial infarction.
Codini MA; Turner DA; Battle WE; Hassan P; Ali A; Messer JV
Am Heart J; 1979 Dec; 98(6):752-62. PubMed ID: 495427
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of coronary reperfusion for acute myocardial infarction by emission CT using technetium-99m pyrophosphate].
Hashimoto T; Kambara H; Nohara R; Fudo T; Uozu K; Tamaki S; Kawai C
J Cardiol; 1987 Jun; 17(2):231-9. PubMed ID: 2966242
[TBL] [Abstract][Full Text] [Related]
7. [Count density method for sizing myocardial infarction with Tc-99m-stannous pyrophosphate myocardial scintigraphy].
Kiriyama T; Kondo T; Watanabe Y; Kaneko K; Kato Y; Sakurai M; Kurokawa H; Hishida H; Mizuno Y; Ejiri K
Kaku Igaku; 1985 Jan; 22(1):75-9. PubMed ID: 3999458
[No Abstract] [Full Text] [Related]
8. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
Tada A; Bungyo H; Hisada K
Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
[No Abstract] [Full Text] [Related]
9. Technetium-99m stannous pyrophosphate myocardial scintiphotos in patients admitted to rule out acute myocardial infarction.
Okada RD; Woolfenden JM; Raessler KL; Groves BM; Marcus RI
Cardiology; 1977; 62(4-6):305-14. PubMed ID: 589613
[TBL] [Abstract][Full Text] [Related]
10. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
Kowalsky RJ; Dalton DR
Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
[TBL] [Abstract][Full Text] [Related]
11. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous display of gated technetium-99m stannous pyrophosphate and gated blood-pool scintigrams.
Corbett JR; Lewis SE; Dehmer G; Bonte FJ; Parkey RW; Buja LM; Willerson JT
J Nucl Med; 1981 Aug; 22(8):671-7. PubMed ID: 7264755
[TBL] [Abstract][Full Text] [Related]
15. Validation of technetium-99m stannous pyrophosphate myocardial scintigraphy for diagnosing acute myocardial infarction more than 48 hours old when serum creatine kinase-MB has returned to normal.
Olson HG; Lyons KP; Butman S; Piters KM
Am J Cardiol; 1983 Aug; 52(3):245-51. PubMed ID: 6869268
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.
Willerson JT; Parkey RW; Bonte FJ; Lewis SE; Corbett J; Buja LM
Semin Nucl Med; 1980 Jan; 10(1):54-69. PubMed ID: 6246640
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
Singh A; Usher M
J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of early positive technetium-99m stannous pyrophosphate scan in predicting reperfusion after thrombolytic therapy for acute myocardial infarction.
Manyari DE; Thompson CR; Duff HJ; Knudtson ML; Kloiber R; Smith ER; Belenkie I
Am J Cardiol; 1988 Jan; 61(1):16-20. PubMed ID: 3337005
[TBL] [Abstract][Full Text] [Related]
19. Correlation of false negative myocardial infarct scintigraphy with postmortem studies.
Codini MA; Hawkins ET; Turner DA
Clin Cardiol; 1981 Jan; 4(1):47-50. PubMed ID: 6892492
[TBL] [Abstract][Full Text] [Related]
20. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction.
Malin FR; Rollo FD; Gertz EW
J Nucl Med; 1978 Oct; 19(10):1111-5. PubMed ID: 722321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
